News | April 28, 2026
Aurigene bets big on CRDMO expansion with $100 million outlay
Deploys $40 million in Hyderabad; advances APIs, peptides, and global small molecule capabilities
Deploys $40 million in Hyderabad; advances APIs, peptides, and global small molecule capabilities
This collaboration sets the stage for WuXi Biologics’ first integrated CRDMO center in the region
His career spans notable tenures at Syngene International Limited, Cipla, Nestlé, and Bharat Petroleum Corporation Limited
Eleven CRDMOs collaborate to form IPSO with the aim to elevate India’s position in the global pharmaceutical value-chain
The CRDMO site will add 120,000L manufacturing capacity to WuXi Biologics’ global network
The biosimilars business generated Rs. 10,431 crore in FY26 revenue, up 16% year-on-year
Both join the leading CRDMO’s executive committee to drive global people strategy and commercial expansion
Steady growth led by biologics and CRDMO business, EBITDA margin at 25% with continued investments in ADCs, peptides, and digital capabilities
CRDMO plans to add 800–1,000 women across scientific and leadership roles over three years
Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals
Subscribe To Our Newsletter & Stay Updated
